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The aim of this study was to better understand the physiological roles of estrogens during the 
process of gonad differentiation in Colossoma macropomum as it is known that ovary 
formation in this species takes place with no transcription of cyp19a1a (the gene that codes for 
aromatase). We treated sexually undifferentiated tambaqui with tamoxifen (Fz; 50mg/kg of 
food), an estrogen receptor blocker, and fadrozole(Tx; 200 mg/kg of food), an aromatase 
inhibitor during 40 and 60 days, respectively. After the treatment, each group was transferred 
to a net cage for further growth, where they remained until sampling of the gonads for sexing. 
Based on sex ratio data, there were no masculinization effect in Fz (55% female, 45% male) 
and Tx treatments (48,8% female, 51,2% male) compared to the control group (44% female, 
56% male). However, in both treatments, differences in size became significant from controls 
five months after the end of chemical administration and remained until the end of experiment. 
Yet the weight of Fz group (260,41 ± 74,91 g) 12 months after termination of treatment was 
significantly higher than control (207,73 ± 77,02 g; p value <0,0001) and Tx group (201,80 ± 
58.74 g; p value <0,0001). In conclusion, this study was able to provide further valuable 
evidence that tambaqui are not sensitive to endocrine-disrupting chemicals that specifically 
interferes with estrogen synthesis and action (via receptor binding) such as tamoxifen and 
fadrozole during gonad development. It remains to be clarified if not estrogen dependent, how 
ovary differentiation is triggered in this species.  
